Nautilus Biotechnology is trading at $2.42, up 5.61%, alongside a strong broader-market rebound, with major U.S. indexes up more than 1.5%.
- No new company-specific announcement was identified for November 9; the investor news page lists Q3 2026 results, released October 27, as the latest news release.
- The supplied price context does not include trading volume, so activity levels cannot be assessed.